Publisher
Springer Science and Business Media LLC
Reference67 articles.
1. Vinayak M, Nisha SS, Rachana S, Pallavi C. Solubility enhancement of labetalol hydrochloride by using liquisolid technique for management of hypertension. Int J Pharm Sci Res. 2022;13:5080–9. https://doi.org/10.13040/IJPSR.0975-8232.13(12).5080-89.
2. The British pharmacopoeia commission secretariat of the medicines and healthcare products, regulatory agency, TSO, The stationary office, London. 2020.
3. The United States Pharmacopoeia, The National Formulary 25 Rockville, MD: US Pharmacopeial Convention, printed version 44, 2021.
4. Mikhail AK, Sergey MS, Nikita S, Ruslan P. Pavel NN (2023) Enantioseparation of β-blockers using silica-immobilised eremomycin derivatives as chiral stationary phases in HPLC. Symmetry. 2023;15:373. https://doi.org/10.3390/sym15020373.
5. Kalkotwar RS, Laghave PK. RP-HPLC method development and validation for determination of labetalol in bulk and marketed formulation. Current Pharma Research. 2018;8:2447–57.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献